Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Polycystic Ovary Syndrome in Type 1 Diabetes
A ClinicalTrials.gov study investigating polycystic ovary syndrome in people with type 1 diabetes, currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes [Phase 1]
This document reports a Phase 1 clinical trial evaluating an immunotherapy vaccine called PIpepTolDC for the treatment of Type 1 Diabetes Me…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: ROME GS System Study [NA]
Senseonics, Inc. has a clinical trial that is currently recruiting for diabetes management, including type 1 and type 2 diabetes. No results…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes [Phase 2]
A Phase 2 trial named INHALE-1st is evaluating Afrezza (insulin human inhalation powder) for youth newly diagnosed with Type 1 diabetes mell…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Type 1 Diabetes Virtual Self-management Education and Support [NA]
A virtual self-management education and support program for people with Type 1 diabetes mellitus is being studied, with recruitment currentl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature [NA]
This is a prospective, multicenter study evaluating the performance and safety of the Eversense Gemini System with a Flash Glucose Measureme…
-
FDA approval · 2026-04-20FDA Approved: TZIELD — Supplemental Application (Provention Bio, Inc.)
The FDA approved a supplemental application for TZIELD (teplizumab-mzwv) from Provention Bio, Inc.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes [EARLY_Phase 1]
This is an early Phase 1 clinical trial evaluating autologous CD6-CAR Treg cells in patients with Stage 3 Type 1 diabetes. The study is curr…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: TArgeting Type 1 Diabetes Using POLyamines (TADPOL) [Phase 2]
A Phase 2 clinical trial (TADPOL) evaluating polyamines for Type 1 Diabetes is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Tirzepatide Use in People With Obesity and Type 1 Diabetes [Phase 4]
A Phase 4 clinical trial update for tirzepatide in people with obesity and Type 1 diabetes, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Study to Evaluate the Safety and Feasibility of Diamyd® in Individuals at Risk for Type 1 Diabetes [Phase 2]
A Phase 2 clinical trial is evaluating the safety and feasibility of Diamyd in individuals at risk for Type 1 diabetes. The study is current…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Effect of Changes in Carbohydrate Intake Patterns on Glucose Control in Patients With Type 1 Diabetes [NA]
A recruiting clinical trial evaluating how carbohydrate intake patterns affect glucose control in people with Type 1 diabetes.
-
EMA approval · 2026-04-17EMA Authorised: Teizeild (teplizumab) — Sanofi Winthrop Industrie
The European Medicines Agency authorised Teizeild (teplizumab) from Sanofi Winthrop Industrie for the treatment of Type 1 diabetes mellitus.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE) [Phase 3]
A Phase 3 study investigating Baricitinib (LY3009104) to preserve beta cell function in children and adults newly diagnosed with Type 1 diab…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults [Phase 3]
Clinical trial update indicating a Phase 3 study of baricitinib (LY3009104) to delay progression to Stage 3 Type 1 diabetes in at-risk child…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Effectiveness of a Combined mHealth-CBT Psychological Intervention to Improve Psychological Well-Being in Young Patients With T1D [NA]
Clinical trial update on the effectiveness of a combined mobile health and cognitive-behavioral therapy intervention to improve psychologica…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
A real-world study evaluating teplizumab in patients with Type 1 diabetes mellitus under managed access programs is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Accessing Care, Clinical Trials and Screening for Underserved Children and Adults With Type 1 Diabetes (ACCESS-T1D)
The ACCESS-T1D trial evaluates access to care, participation in clinical trials, and screening for underserved children and adults with Type…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Long-Term Outcomes of Teplizumab in Routine Clinical Care
An ongoing clinical trial is evaluating long-term outcomes of teplizumab used in routine clinical care for individuals with Type 1 diabetes.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Food is Medicine in Pediatric Patients With Diabetes [NA]
This clinical trial update describes a study evaluating 'Food is Medicine' in pediatric patients with Type 1 diabetes; the trial is not yet …
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Improving Transition Care for Adolescents and Young Adults With Type 1 Diabetes [NA]
This clinical trial update from Virginia Commonwealth University focuses on improving transition care for adolescents and young adults with …
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Effect of Low-intensity Aerobic Regular Activity on Heart Rate Variability in Type 1 Diabetes [NA]
Clinical trial examining whether low-intensity aerobic activity alters heart rate variability in Type 1 diabetes; the study is currently act…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus [NA]
A clinical trial is evaluating the impact of the Accu-Chek SmartGuide continuous glucose monitoring system on time-in-range compared with se…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes [Phase 3]
A Phase 3 clinical trial update reports that Diamyd is being studied in newly diagnosed Type 1 diabetes to assess preservation of insulin pr…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults [NA]
Clinical trial comparing Omnipod 5 with Libre 2 versus multiple daily injections in children and adults with Type 1 diabetes mellitus has co…